Gardasil Anal Cancer Indication To Face FDA Advisory Committee Scrutiny

Supplemental application filed earlier this year is part of Merck's strategy to broaden use of the HPV vaccine, although its bid to expand the label to women ages 27-45 has thus far been blocked by the agency.